BRCA1 screening in patients with a family history of breast or ovarian cancer

Genetic Testing

Volumn 3, Issue 2, 1999, Pages 223-226

  Arver, Brita ^a   Claro, Antonio ^a   Langerød, Anita ^b   Børresen Dale, Anne Lise ^b   Lindblom, Annika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SCREENING; EXON; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; OVARY CANCER; PEDIGREE ANALYSIS; SWEDEN;

EID: 0032780922     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.1999.3.223     Document Type: Article

References (19)

1. ABELIOVICH, D., KADURI, L., LERER, I., WEINBERG, N., AMIR, G., SAGI, M., ZLOTOGORA, J., HECHING, N., and PERETZ, T. (1997). The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am. J. Hum. Genet. 60, 505-514.
2. CASTILLA, L.H., COUCH, F.J., ERDOS, M.R., HOSKINS, K.F., CALZONE, K., GARBER, J.E., BOYD, J., LUBIN, M.D., DESHANO, M.L., BRODY, L.C., COLLINS, F.S., and WEBER, B.L. (1994). Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nature Genet. 8, 387-391.
3. CHEN, J., ZELADA HEDMAN, M., WASTESON ARVER, B., SIGURDSSON, S., EYFJÖRD, J.E., and LINDBLOM, A. (1998). BRCA2 germline mutations in Swedish breast cancer families. Eur. J. Hum. Genet. 6, 134-139.
4. CLAUS, E.B., RISCH, N., and THOMPSON, W.D. (1991). Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am. J. Hum. Genet. 48, 232-242.
5. FORD, D., EASTON, D.F., STRATTON, M., NAROD, S., GOLDGAR, D., DEVILEE, P., BISHOP, D.T., WEBER, B., LENOIR, G., CHANG-CLAUDE, J., SOBOL, H., TEARE, M.D., STREUEWING, J., ARASON, A., SCHERNECK, S., PETO, J., REBBECK, T.R., TONIN, P., NEUHAUSEN, S., BARKADOTTIR, R., EYFJORD, J., LYNCH, H., PONDER, B.A.J., GAYTHER, S.A., BIRCH, J.M., LINDBLOM, A., STOPPA-LYONNET, D., BIGNON, Y., BORG, Å., HAMANN, U., HAITES, N., SCOTT, R.J., MAUGARD, C.M., VASEN, H., SEITZ, S., CANNON-ALBRIGHT, L.A., SCHOFIELD, A., ZELADA-HEDMAN, M., and The Breast Cancer Linkage Consortium. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet. 62, 676-689.
6. HALL, J.M., LEE, M.K., NEWMAN, B., MORROW, J.E., ANDERSON, L.A., HUEY, B., and KING, M.C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250, 1684-1689.
7. HOGERVORST, F.B.L., CORNELIS, R.S., BOUT, M., VAN VLIET, M., OOSTERWIJK, J.C., OLMER, R., BAKKER, B., KLIJN, J.G.M., VASEN, H.F.A., MEIJERS-HEIJBOER, H., MENKO, F.H., CORNELISSE, C.J., DEN DUNNEN, J.T., DEVILEE, P., and VAN OMMEN, G.-J.B. (1995). Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet. 10, 208-212.
8. IKDAHL ANDERSEN, T., EIKEN, H.G., COUCH, F., KAADA, G., SKREDE, M., JOHNSEN, H., ALOYSIUS, T.A., TVEIT, K.M., TRANEBJAERG, L., DØRUM, A., MÖLLER, P., WEBER, B.L., and BØRRESEN-DALE, A.-L. (1998). Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Hum. Mutat. 11, 166-174.
9. JOHANNSSON, O., OSTERMEYER, E.A., HÅKANSSON, S., FRIEDMAN, L.S., JOHANSSON, U., SELLBERG, G., BRØNDUM-NIELSEN, K., SELE, V., OLSSON, H., KING, M.-C., and BORG, Å. (1996). Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am. J. Hum. Genet. 58, 441-450.
10. LEVY-LAHAD, E., CATANE, R., EISENBERG, S., KAUFMAN, B., HORNREICH, G., LISHINSKY, E., SHOHAT, M., WEBER, B.L., BELLER, U., LAHAD, A., and HALLE, D. (1997). Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am. J. Hum. Genet. 60, 1059-1067.
11. MIKI, Y., SWENSEN, J., SHATTUCK-EIDENS, D., FUTREAL, P.A., HARSHMAN, K., TAVTIGIAN, S., LIU, Q., COCHRAN, C., BENNET, L.M., DING, W., BELL, R., ROSENTHAL, J., HUSSEY, C. TRAN, T., McCLURE, M., FRYE, C., HATTIER, T., PHELPS, R., HAUGEN-STRANO, A., KATCHER, H., YAKUMO, K., GHOLAMI, Z., SHAFFER, D., STONE, S., BAYER, S., WRAY, C., BOGDEN, R., DAYANANTH, P., WARD, J., TONIN, P., NAROD, S., BRISTOW, P.K., NORRIS, F.H., HELVERING, L., MORRISON, P., ROSTECK, P., LAI, M., BARRETT, J.C., LEWIS, C., NEUHAUSEN, S., CANNON-ALBRIGHT, L., GOLDGAR, D., WISEMAN, R., KAMB, A., and SKOLNICK, M.H. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
12. NAROD, S.A., FEUNTEUN, J., LYNCH, H.T., WATSON, P., CONWAY, T., LYNCH, J., and LENOIR, G.M. (1991). Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338, 82-83.
13. NEWMAN, B., AUSTIN, M.A., LEE, M., and KING, M.-C. (1988). Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc. Natl. Acad. Sci. USA 85, 3044-3048.
14. SEROVA, O.M., MAZOYER, S., PUGET, N., DUBOIS, V., TONIN, P., SHUGART, Y.Y., GOLDGAR, D., NAROD, S.A., LYNCH, H.T., and LENOIR, G.M. (1997). Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am. J. Hum. Genet. 60, 486-495.
15. SRIVASTAVA, A.K., MONTANARO, V., and KERE, J. (1992).Simplified template preparation and improved direct sequencing using Taq polymerase. PCR Methods Appl. 1, 255-256.
16. STEICHEN-GERSDORF, E., GALLION, H.H., FORD, D., GIRODET, C., EASTON, D.F., DiCIOCCIO, R.A., EVANS, G., PONDER, M.A., PYE, C., MAZOYER, S., NOGUCHI, T., KARENGUEVEN, F., SOBEL, H., HARDOUIN, A., BIGNON, Y.-J., PIVER, M.S., SMITH, S.A., and PONDER, B.A.J. (1994). Familial site-specific ovarian cancer is linked to BRCA1 on 17q12-21. Am. J. Hum. Genet. 55, 870-875.
17. THORLACIUS, S., SIGURDSSON, S., BJARNADOTTIR, H., OLAFSDOTTIR, G., JONASSON, J.G., TRYGGVADOTTIR, L., TULINIUS, H., and EYFJÖRD, J.E. (1997). Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet. 60, 1079-1084.
18. WOOSTER, R., BIGNELL, G., LANCASTER, J., SWIFT, S., SEAL, S., MANGION, J., COLLINS, N., GREGORY, S., GUMBS, C., MICKLEM, G., BARFOOT, R., HAMOUDI, R., PATEL, S., RICE, C., BIGGS, P., HASHIM, Y., SMITH, A., CONNOR, F., ARASON, A., GUDMUNDSSON, J., FICENEC, D., KELSELL, D., FORD, D., TONIN, P., BISHOP, D.T., SPURR, N.K., PONDER, B.A.J., EELES, R., PETO, J., DEVILEE, P., CORNELISSE, C., LYNCH, H., NAROD, S., LENOIR, G., EGILSSON, V., BJORK BARKADOTTIR, R., EASTON, D.F., BENTLEY, D.R., FUTREAL, P.A., ASHWORTH, A., and STRATTON, M.R. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792.
19. ZELADA-HEDMAN, M., WASTESON ARVER, B., CLARO, A., CHEN, J., WERELIUS, B., KOK, H., SANDELIN, K., HÅKANSSON, S., IKDAHL ANDERSEN, T., BORG, Å., BØRRESENDALE, A.-L., and LINDBLOM, A. (1997). A screening for BRCA1 mutations in breast and breast ovarian families from the Stockholm region. Cancer Res. 57, 2474-2477.